BioLumic and the International Rice Research Institute (IRRI) have launched field trials in the Philippines to test a light-activated seed technology aimed at protecting rice yields while reducing water use and methane emissions in direct-seeded rice (DSR) systems. The trials mark a step toward commercial deployment across major rice-growing regions, with support from the Gates Foundation.
The technology, BioLumic's xTraits platform, uses specific light treatments to activate or suppress gene expression in seeds without chemical inputs or genetic modification. By harnessing photomorphogenesis—the natural process by which light regulates plant development—xTraits aims to unlock trait potential already present within the seed, enabling targeted trait activation without requiring farmers to change their growing practices.
DSR is a lower-water, lower-emission alternative to traditional flooded rice production, and it is particularly relevant across South Asia, where water scarcity and labor constraints are increasing pressure on farmers. By reducing the need for continuous flooding, DSR can cut water consumption and methane emissions, but it also presents challenges such as weed competition and yield stability. The BioLumic-IRRI trials will evaluate whether light-activated seed traits can help overcome these challenges and make DSR a more viable option for farmers.
The program's importance extends beyond individual farms. Rice is a staple food for billions of people and a major source of agricultural methane emissions. If the technology proves effective, it could offer a scalable way to reduce the environmental footprint of rice production while safeguarding yields. The involvement of IRRI, a leading rice research institution, lends scientific credibility to the effort. According to IRRI, the institute is dedicated to abolishing poverty and hunger among people who depend on rice-based agri-food systems, and promoting environmental sustainability in a world challenged by climate change.
BioLumic, founded in 2013 and based in the U.S. and New Zealand, is pioneering expression-based, heritable traits that improve crop performance without altering DNA. Its patented xTraits Platform uses proprietary Light Recipes to program coordinated genetic expression at the parent seed stage, delivering polygenic, heritable gains in yield, resilience, and nutrition with no genetic modification, no rebreeding, and no regulatory burden. The company states that xTraits integrate directly into existing breeding and seed production pipelines and stack with current trait technologies. More information is available at www.biolumic.com.
The field trials will generate data on how the technology performs under real-world conditions, a critical step before commercialization. For farmers in water-stressed regions, the outcome could mean access to a tool that helps maintain productivity while using fewer resources. For the broader food system, it could represent a pathway to lower-emission rice cultivation that does not require sacrificing yield. The full announcement from BioLumic provides additional details on the trial design and objectives.
